Sobre 16 señales de compra con un rendimiento T+90 consolidado. Base de rendimiento: cierre del día siguiente a la publicación.
Historial de señales
Explore the detailed record of transactions filed by Krogulski Kenneth, Consejero. Director active across 1 company, notably Cumberland Pharmaceuticals INC. Aggregated, 47 reports have been published. Breakdown: 23 buys · 0 sell. Total volume traded: €6k. Activity tracked since 17 March 2021. The latest transaction was filed on 18 March 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Krogulski Kenneth
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
280 títulos@ 2,24 US$1.2% de su flujoCommon StockSEC:0001214659-23-014538:0
25 de 47 declaraciones
About Krogulski Kenneth
Krogulski Kenneth is Administrateur at Cumberland Pharmaceuticals INC (XNAS). He has 47 filings in total, and across the 47 sampled filings, buys amount to EUR 5889 and sells to EUR 0, with filings ranging from 2021-06-11 to 2026-03-20. The most frequent transaction nature is Acquisition.